Paliperidone palmitate (Xeplion®)



Assessment Status Rapid Review Complete
Drug Paliperidone palmitate
Brand Xeplion®
Indication For maintenance treatment of schizophrenia in adult patients stabilised with paliperidone or risperidone. In selected adult patients with schizophrenia and previous responsiveness to oral paliperidone or risperidone, Xeplion may be used without prior stabilisation with oral treatment if psychotic symptoms are mild to moderate, and a long acting injectable treatment is needed.
Assessment Process
Rapid review commissioned 23/03/2011
Rapid review completed 09/04/2011